CEO & Co-Founder
at Dyno Therapeutics
Eric Kelsic, PhD, is the CEO and co-founder of Dyno Therapeutics. Prior to founding Dyno, Eric led a team to develop the technology underlying Dyno’s artificial intelligence-powered capsid engineering platform in Prof. George Church’s lab at the Wyss Institute of Harvard Medical School. There, he measured the first comprehensive fitness landscape of the AAV capsid protein and co-discovered the AAV MAAP gene. He earned a PhD in Systems Biology from Harvard University and a BS in Physics from Caltech. Dyno was named Xconomy’s 2020 Startup of the Year and Eric was recognized as one of Endpoint’s 20 under 40 next-gen biotech leaders in 2021.
Accreditations
Doctor of Philosophy (PhD) recognised by Harvard University
Bachelor of Science recognised by Caltech University
Areas of Expertise
Got a Question for Eric Kelsic, PhD?
Get in touch using the contact form linked here and we’ll get back to you shortly.
